A milestone for Santa Cruz medtech firm Capstan leads Jessica M. Pasko's weekly survey of local business. She's also got news on downtown development, coming events to put in your calendar and more.

Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...

Aortic stenosis, a narrowing of the aortic valve, is one of the most common and severe structural issues, particularly in ...

Capstan Medical’s robot platform has been used for the first in-human robotic assisted transcatheter mitral valve replacement ...

Led by Boston Scientific, the funding will expedite the clinical development and commercialisation of 4C Medical’s ...

"Today marks a pivotal moment in the evolution of structural heart therapy," Capstan Medical CEO Maggie Nixon said.

Capstan Medical announced its first in-human cardiac valve replacements using its catheter-based robotic surgical platform.

Capstan CEO Maggie Nixon discusses first-in-human feedback, the all-at-once approach, regulatory strategy and the tricuspid ...

The money will support an ongoing pivotal trial of 4C Medical Technologies' transcatheter mitral valve replacement device in ...

C Medical Technologies Inc. raised $175 million in a series D financing round led by Boston Scientific Corp. The financing will support the regulatory trials and commercialization of the Altavalve ...

C Medical Technologies, Inc. ("4C Medical"), a medical device company dedicated to advancing minimally invasive therapies for structural heart disease, today announced the closing of its Series D ...

We anticipate Livanova can bring leverage down to the target range by 2027, which would put the firm's debt at levels typical of medtech firms. Interest coverage remains well within covenants, though, ...